Ann Surg Oncol. 1999 Oct-Nov;6(7):640-4. doi: 10.1007/s10434-999-0640-0.
PMID:10560848
[Organ-sparing therapy for testicular cancer].
Breunig C, Schrader M, Schrader AJ, Zengerling F.
Urologe A. 2014 Sep;53(9):1302-9. doi: 10.1007/s00120-014-3556-7.
PMID:25142787
Hyperphosphatemic Familial Tumoral Calcinosis.
Ramnitz MS, Gafni RI, Collins MT.
2018 Feb 1. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
PMID:29389098
Testicular Leydig Cell Tumor with Metachronous Lesions: Outcomes after Metastasis Resection and Cryoablation.
Geminiani JJ, Marshall SD, Ho TS, Brandes SB.
Case Rep Urol. 2015;2015:748495. doi: 10.1155/2015/748495. Epub 2015 Oct 7.
PMID:26525589
Salvage Strategies for Management of Testicular Tumors.
Chatterjee S, Rawal SK.
Indian J Surg Oncol. 2017 Sep;8(3):389-396. doi: 10.1007/s13193-016-0614-1. Epub 2017 Jun 6.
PMID:36118409
Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice.